Episode 13 - Medicines Reclassification with William Allan

https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/6f/4e/d7/6f4ed7b1-1bf4-148f-14e8-0770038de55c/mza_7325392877382738825.jpg/600x600bb.jpg

PSNZ - Pharmacy in Focus

PSNZ

18 episodes

6 days ago

Pharmacy in Focus is brought to you by Shirena Vasan on behalf of the Pharmaceutical Society of New Zealand. Pharmacy in Focus episodes are pocket-sized conversations on current topics and interests relating to pharmacy and the wider health sector in New Zealand.

Medicine

Health & Fitness

RSS

All content for PSNZ - Pharmacy in Focus is the property of PSNZ and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/23694615/23694615-1649106608314-957bab55f884e.jpg

Episode 13 - Medicines Reclassification with William Allan

PSNZ - Pharmacy in Focus

18 minutes 43 seconds

3 years ago

Episode 13 - Medicines Reclassification with William Allan

When applying for a medicine to be reclassified, there is a set process that is followed. However, the COVID-19 antivirals did not follow this process and were reclassified through a specific legislation in the Medicines Act.

In this episode I talk to Billy Allan, Manager Pharmacy, Te Whatu Ora, Health New Zealand to find out about the usual medicine reclassification process, and also why the COVID-19 antivirals were reclassified under this different mechanism.